Bausch + Lomb Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bausch + Lomb Corporation on June 1, 2023. The report addresses a specific corporate governance event regarding the reshaping of the Company's executive leadership team.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
On June 1, 2023, Joseph F. Gordon transitioned from his role as President, Global Consumer, Surgical and Vision Care to the new position of strategic advisor to the Chairman and Chief Executive Officer. This change is effective immediately as of the filing date.
Management Commentary and Risks
Mr. Gordon remains subject to the existing terms and conditions of his employment agreement dated August 2, 2018 (as amended). No new risks, contingencies, or unusual items were disclosed in this filing. The Company did not provide updated guidance or outlook in this specific report.
Investor Verification Checklist
- Verify the specific responsibilities of the new "strategic advisor" role for Joseph F. Gordon.
- Review the referenced employment agreement (Exhibits 10.18 and 10.19 to the 2022 Form 10-K) to understand compensation implications of the role change.
- Confirm if a successor has been named for the President, Global Consumer, Surgical and Vision Care role.